(R)-Salbutamol

This page contains recent news articles, when available, and an overview of (R)-Salbutamol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Bid to help obese lose weight the wheezy way  -  20 Apr 2009
An Australian firm is in talks to develop a slow-release capsule form of salbutamol, known as r-salbutamol, which it claims can reduce body weight by 2 to 3 Brisbane Times

Canadian swine for Stirling  -  ‎Apr 13, 2009‎
Stirling Products’ North American subsidiary has signed an agreement with Canada’s national research council for a trial of its lead candidate R-salbutamol Australian Life Scientist

Grey knight to Stirling's rescue  -  ‎Mar 12, 2009‎
He was, however, instrumental in bringing to Stirling its main asset — rights over the use of an agent called R-salbutamol to produce products for reducing The Age

Stirling Products gets lifeline  -  04 Feb 2009
Aquience Inc over the PetQuench product and ceased its distribution deal with South African business Afgri Operations over the R-salbutamol product. WA Business News (subscription),

Stirling Products (ASX:STI) Gets First Approval For Obesity Patent  -  Nov 6, 2008
R-salbutamol application for treatment of overweight mammals and birds. - First Approval received from New Zealand Patent Office. ABN Newswire (press release),

Stirling Products (ASX:STI) Announces Consolidation Of Stirling ...  Sep 10, 2008
...flexibility and the opportunity for growth right through to the introduction of Ralbolean(TM), the company's R-salbutamol treatment for obesity in dogs.ABN Newswire (press release),

Stirling Products (ASX:STI) Gets Australian Patent For Heaves In ...  -  Jul 28, 2008
The company announced in January last year (ASX, January 18, 2007) that R-salbutamol when delivered through the Equinehaler(tm) delivery system (an ABN Newswire (press release),

Heaves hit for Stirling  -  Jul 28, 2008
Stirling Products [ASX: STI] has been granted an Australian patent or the treatment of heaves in horses with R-salbutamol. The company has already been Australian Life Scientist,

Stirling Products Launches Companion  -  Jun 13, 2008
R-albuterol (R-salbutamol) is the pure, active enantiomer of the asthma medication albuterol, which has been used in humans for over 25 years. Ad-Hoc-News (Pressemitteilung),

Stirling Products (ASX:STI) Signs Term Sheet For Novel Insecticide  -  Jun 15, 2008
..."This is the third tier of products to be added to Stirling's original portfolio of products, focused on R-salbutamol. As we have indicated, Stirling needs ABN Newswire (press release),

Stirling Products (ASX:STI) Signs With Aquience For Companion ...  -  Jun 3, 2008
...animals as a forerunner to products under development from its own technology platforms; the main one being R-salbutamol for treating obesity in dogs. ABN Newswire (press release),

Stirling Products (ASX:STI) Signs UK Agreement For Equine ...  -  Mar 9, 2008
...for international markets to treat equine respiratory disorders commencing with the use of R- salbutamol and the Equidel(tm) delivery device. ABN Newswire (press release),

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.